Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

280
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
280
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

394
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
394
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

258
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
258
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

196
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
196
Cancer Survival Analysis01:21

Cancer Survival Analysis

448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Censoring Survival Data01:09

Censoring Survival Data

228
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
228

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardized mean differences in meta-analysis: A tutorial.

Cochrane evidence synthesis and methods·2025
Same author

Standardised mean difference.

BMJ evidence-based medicine·2025
Same author

Risk ratios, odds ratios and the risk difference.

BMJ evidence-based medicine·2024
Same author

Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane.

BMJ evidence-based medicine·2023
Same author

Advocating for evidence-informed decisions to make healthcare fit for each person.

BMJ evidence-based medicine·2022
Same author

Development of a checklist to detect errors in meta-analyses in systematic reviews of interventions: study protocol.

F1000Research·2021
Same journal

Correction to: "Should We Adopt the Case Report Format to Report Challenges in Complicated Evidence Synthesis? A Proposal and Illustration of a Case Report of a Complex Search Strategy for Humanitarian Interventions" and "A New Process Model of Study Identification Specific to the Identification of Randomised Studies for Systematic Reviews of Medical Interventions".

Cochrane evidence synthesis and methods·2026
Same journal

Reinterpreting I<sup>2</sup> Thresholds: Toward Context-Specific Heterogeneity Assessment in Evidence Synthesis.

Cochrane evidence synthesis and methods·2026
Same journal

Better Together: Tools to Aid Patient and Public Involvement in Evidence Synthesis and the Need for Consensus on Essential Reporting Items.

Cochrane evidence synthesis and methods·2026
Same journal

An Open-Source Systematic Reviews Integrated System (OSSYRIS) - Streamlining Processes and Standardising Data Structures.

Cochrane evidence synthesis and methods·2026
Same journal

RETRACTION: Human-in-the-Loop Artificial Intelligence System for Systematic Literature Review: Methods and Validations for the AutoLit Review Software.

Cochrane evidence synthesis and methods·2026
Same journal

Do We Need Systematic Reviews of Research Priority Setting? A Proposal for a New Concept on Conducting Systematic Reviews of Research Priority Setting Exercises.

Cochrane evidence synthesis and methods·2026
See all related articles

Related Experiment Video

Updated: Sep 9, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Meta-Analysis Using Time-to-Event Data: A Tutorial.

Ashma Krishan1, Kerry Dwan2

  • 1Centre for Biostatistics The University of Manchester, Manchester Academic Health Science Centre Manchester UK.

Cochrane Evidence Synthesis and Methods
|August 28, 2025
PubMed
Summary
This summary is machine-generated.

This tutorial explains hazard ratios for time-to-event data in meta-analysis. Learn interpretation and calculation methods with practical examples and a micro learning module.

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

694
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Related Experiment Videos

Last Updated: Sep 9, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

694
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology

Background:

  • Time-to-event data is crucial in clinical trials.
  • Meta-analysis of such data requires specific statistical approaches.

Purpose of the Study:

  • To provide a tutorial on understanding and utilizing hazard ratios.
  • To demonstrate the inclusion of time-to-event data in meta-analysis.

Main Methods:

  • Explanation of hazard ratios and their interpretation.
  • Demonstration of meta-analysis techniques for time-to-event data.
  • Provision of a micro learning module for hands-on practice.

Main Results:

  • Clear explanations of hazard ratio concepts.
  • Practical examples illustrating meta-analysis with time-to-event data.
  • Interactive practice opportunities for hazard ratio calculation.

Conclusions:

  • Enhanced understanding of hazard ratios for researchers.
  • Improved ability to conduct meta-analyses with time-to-event outcomes.
  • Accessible learning resources for biostatistical methods in clinical research.